Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
CENTA
Deeply undervalued
CENTRAL GARDEN & PET CO
Price$35.00
Model IV$73.39
P/IV0.48
Discount 52%
Return to IV: +109.7%
Market implies -7.2%/yr
vs model +3.1% · below model
CENX
Valuation N/A
CENTURY ALUMINUM CO
Price$36.76
Model IV—
P/IV—
Market implies +89.4%/yr
CFR
Overvalued
CULLEN/FROST BANKERS, INC.
Price$150.24
Model IV$128.63
P/IV1.21
Premium +17%
Return to IV: -14.4%
CGABL
Valuation N/A
Carlyle Group Inc.
Price$15.46
Model IV—
P/IV—
Market implies +73.3%/yr
CGAU
Deeply overvalued
Centerra Gold Inc.
Price$22.54
Model IV$15.50
P/IV1.45
Premium +45%
Return to IV: -31.2%
Market implies +11.8%/yr
vs model +8.0% · above model
CGON
Valuation N/A
CG Oncology, Inc.
Price$63.82
Model IV—
P/IV—
Market implies +74.8%/yr
CHA
Overvalued
Chagee Holdings Ltd.
Price$11.25
Model IV$9.01
P/IV1.25
Premium +25%
Return to IV: -19.9%
Market implies +9.5%/yr
vs model +8.0% · in line
CHDN
Deeply undervalued
Churchill Downs Inc
Price$79.96
Model IV$180.81
P/IV0.44
Discount 56%
Return to IV: +126.1%
Market implies -2.3%/yr
vs model +10.5% · below model
CHE
Fairly valued
CHEMED CORP
Price$499.82
Model IV$494.83
P/IV1.01
Premium +1%
Return to IV: -1.0%
Market implies +6.8%/yr
vs model +8.3% · in line
CHEF
Deeply overvalued
Chefs' Warehouse, Inc.
Price$114.32
Model IV$32.88
P/IV3.30
Premium +248%
Return to IV: -71.2%
Market implies +21.7%/yr
vs model +6.7% · above model
CHH
Overvalued
CHOICE HOTELS INTERNATIONAL INC /DE
Price$105.64
Model IV$89.29
P/IV1.18
Premium +18%
Return to IV: -15.5%
Market implies +9.3%/yr
vs model +8.8% · in line
CHRD
Deeply undervalued
Chord Energy Corp
Price$141.54
Model IV$262.77
P/IV0.52
Discount 46%
Return to IV: +85.7%
Market implies -4.6%/yr
vs model +4.9% · below model
CHRN
Valuation N/A
ChronoScale Holdings Corp
Price$18.59
Model IV—
P/IV—
Market implies +43.7%/yr
CHWY
Deeply overvalued
Chewy, Inc.
Price$18.95
Model IV$12.91
P/IV1.55
Premium +47%
Return to IV: -31.9%
Market implies +12.1%/yr
vs model +8.6% · above model
CHYM
Deeply overvalued
Chime Financial, Inc.
Price$30.08
Model IV$7.82
P/IV3.66
Premium +285%
Return to IV: -74.0%
Market implies +25.5%/yr
vs model +30.8% · below model
CIFR
Valuation N/A
Cipher Digital Inc.
Price$13.52
Model IV—
P/IV—
Market implies +69.3%/yr
CIGI
Overvalued
Colliers International Group Inc.
Price$86.60
Model IV$66.96
P/IV1.34
Premium +29%
Return to IV: -22.7%
Market implies +7.8%/yr
vs model +5.2% · in line
CII
Valuation N/A
BlackRock Enhanced Large Cap Core Fund, Inc.
Price$24.33
Model IV—
P/IV—
Limited data — see page
CIMN
Overvalued
CHIMERA INVESTMENT CORP
Price$25.00
Model IV$20.93
P/IV1.20
Premium +19%
Return to IV: -16.3%
CIMO
Overvalued
CHIMERA INVESTMENT CORP
Price$25.13
Model IV$20.93
P/IV1.21
Premium +20%
Return to IV: -16.7%
CIMP
Overvalued
CHIMERA INVESTMENT CORP
Price$24.88
Model IV$21.56
P/IV1.16
Premium +15%
Return to IV: -13.3%
CLBK
Overvalued
Columbia Financial, Inc.
Price$10.80
Model IV$8.31
P/IV2.42
Premium +30%
Return to IV: -23.1%
CLBT
Fairly valued
Cellebrite DI Ltd.
Price$11.26
Model IV$12.88
P/IV0.91
Discount 13%
Return to IV: +14.4%
Market implies +8.9%/yr
vs model +13.8% · below model
CLDX
Valuation N/A
Celldex Therapeutics, Inc.
Price$29.89
Model IV—
P/IV—
Market implies +145.1%/yr
vs model +2.0% · above model
CLF
Deeply undervalued
CLEVELAND-CLIFFS INC.
Price$12.98
Model IV$19.40
P/IV0.70
Discount 33%
Return to IV: +49.5%
Market implies -8.3%/yr
vs model +0.0% · below model
CLMT
Valuation N/A
Calumet, Inc. /DE
Price$56.42
Model IV—
P/IV—
Market implies +37.6%/yr
vs model +0.0% · above model
CLOV
Valuation N/A
CLOVER HEALTH INVESTMENTS, CORP. /DE
Price$4.79
Model IV—
P/IV—
Limited data — see page
CLSK
Deeply overvalued
CLEANSPARK, INC.
Price$10.50
Model IV$4.33
P/IV4.22
Premium +142%
Return to IV: -58.7%
Market implies +21.5%/yr
vs model +50.0% · below model
CMBT
Valuation N/A
CMB.TECH NV
Price$20.60
Model IV—
P/IV—
Limited data — see page
CMC
Deeply overvalued
COMMERCIAL METALS Co
Price$63.89
Model IV$30.81
P/IV2.47
Premium +107%
Return to IV: -51.8%
Market implies +14.1%/yr
vs model +4.1% · above model
CMCM
Deeply undervalued
Cheetah Mobile Inc.
Price$2.48
Model IV$7.32
P/IV0.36
Discount 66%
Return to IV: +195.2%
Market implies -17.8%/yr
vs model +7.5% · below model
CMSA
Overvalued
CMS ENERGY CORP
Price$19.14
Model IV$15.53
P/IV1.38
Premium +23%
Return to IV: -18.9%
CMSC
Overvalued
CMS ENERGY CORP
Price$19.95
Model IV$16.42
P/IV1.38
Premium +21%
Return to IV: -17.7%
CMSD
Overvalued
CMS ENERGY CORP
Price$20.04
Model IV$16.56
P/IV1.38
Premium +21%
Return to IV: -17.4%
CNF
Valuation N/A
CNFinance Holdings Ltd.
Price$1.95
Model IV—
P/IV—
Limited data — see page
CNK
Deeply undervalued
Cinemark Holdings, Inc.
Price$36.40
Model IV$147.53
P/IV0.25
Discount 75%
Return to IV: +305.3%
Market implies -27.7%/yr
vs model +19.8% · below model
CNM
Undervalued
Core & Main, Inc.
Price$40.35
Model IV$51.47
P/IV0.84
Discount 22%
Return to IV: +27.6%
Market implies +2.9%/yr
vs model +7.6% · below model
CNO
Fairly valued
CNO Financial Group, Inc.
Price$52.99
Model IV$49.21
P/IV0.93
Premium +8%
Return to IV: -7.1%
CNR
Deeply undervalued
Core Natural Resources, Inc.
Price$88.46
Model IV$162.22
P/IV0.55
Discount 45%
Return to IV: +83.4%
Market implies -1.3%/yr
vs model +8.0% · below model
CNS
Valuation N/A
COHEN & STEERS, INC.
Price$69.26
Model IV—
P/IV—
Market implies +31.7%/yr
CNTA
Valuation N/A
Centessa Pharmaceuticals plc
Price$40.50
Model IV—
P/IV—
Market implies +83.7%/yr
vs model +15.0% · above model
CNX
Fairly valued
CNX Resources Corp
Price$34.03
Model IV$34.23
P/IV0.96
Discount 1%
Return to IV: +0.6%
Market implies +3.2%/yr
vs model +3.9% · in line
CNXN
Deeply overvalued
PC CONNECTION INC
Price$92.81
Model IV$27.35
P/IV3.18
Premium +239%
Return to IV: -70.5%
Market implies +20.4%/yr
vs model +4.2% · above model
COCO
Deeply overvalued
Vita Coco Company, Inc.
Price$58.39
Model IV$19.82
P/IV3.01
Premium +195%
Return to IV: -66.1%
Market implies +8.6%/yr
vs model +12.6% · below model
COE
Valuation N/A
51Talk Online Education Group
Price$12.22
Model IV—
P/IV—
Market implies +24.8%/yr
COGT
Valuation N/A
Cogent Biosciences, Inc.
Price$31.00
Model IV—
P/IV—
Limited data — see page
COHU
Valuation N/A
COHU INC
Price$68.19
Model IV—
P/IV—
Market implies +20.8%/yr
COLB
Fairly valued
COLUMBIA BANKING SYSTEM, INC.
Price$28.37
Model IV$32.62
P/IV0.91
Discount 13%
Return to IV: +15.0%
COLD
Fairly valued
AMERICOLD REALTY TRUST
Price$13.99
Model IV$14.37
P/IV1.09
Discount 3%
Return to IV: +2.7%
COLM
Fairly valued
COLUMBIA SPORTSWEAR CO
Price$57.04
Model IV$59.03
P/IV0.99
Discount 3%
Return to IV: +3.5%
Market implies +4.9%/yr
vs model +6.2% · in line
COMP
Overvalued
Compass, Inc.
Price$9.39
Model IV$7.53
P/IV1.22
Premium +25%
Return to IV: -19.8%
Market implies +8.2%/yr
vs model +2.0% · above model
CON
Fairly valued
Concentra Group Holdings Parent, Inc.
Price$37.19
Model IV$37.81
P/IV0.66
Discount 2%
Return to IV: +1.7%
Market implies +6.6%/yr
vs model +8.5% · in line
CORZ
Valuation N/A
Core Scientific, Inc./tx
Price$15.41
Model IV—
P/IV—
Market implies +48.8%/yr
vs model +2.0% · above model
CORZW
Valuation N/A
Core Scientific, Inc./tx
Price$8.74
Model IV—
P/IV—
Market implies +40.0%/yr
vs model +2.0% · above model
CORZZ
Valuation N/A
Core Scientific, Inc./tx
Price$15.23
Model IV—
P/IV—
Market implies +137.0%/yr
vs model +2.0% · above model
CPA
Valuation N/A
Copa Holdings, S.A.
Price$134.23
Model IV—
P/IV—
Limited data — see page
CPAC
Valuation N/A
CEMENTOS PACASMAYO SAA
Price$12.27
Model IV—
P/IV—
Limited data — see page
CPB
Deeply undervalued
CAMPBELL'S Co
Price$19.21
Model IV$41.61
P/IV0.48
Discount 54%
Return to IV: +116.6%
Market implies -6.2%/yr
vs model +4.5% · below model
CPK
Deeply overvalued
CHESAPEAKE UTILITIES CORP
Price$127.75
Model IV$89.70
P/IV1.37
Premium +42%
Return to IV: -29.8%
CPRX
Deeply undervalued
CATALYST PHARMACEUTICALS, INC.
Price$31.49
Model IV$82.62
P/IV0.38
Discount 62%
Return to IV: +162.4%
Market implies +6.0%/yr
vs model +25.0% · below model
